Viking Global Investors LP Roivant Sciences Ltd. Transaction History
Viking Global Investors LP
- $25.8 Billion
- Q3 2024
A detailed history of Viking Global Investors LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Viking Global Investors LP holds 54,099,066 shares of ROIV stock, worth $575 Million. This represents 2.42% of its overall portfolio holdings.
Number of Shares
54,099,066
Previous 69,155,846
21.77%
Holding current value
$575 Million
Previous $731 Million
14.59%
% of portfolio
2.42%
Previous 2.91%
Shares
6 transactions
Others Institutions Holding ROIV
# of Institutions
312Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$701 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$699 Million73.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$443 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$376 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.7MShares$315 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.49B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...